The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function (Q24307921)

3

0 references

author name string

Robert J Johnston

1

0 references

Laetitia Comps-Agrar

2

0 references

Xin Yu

4

0 references

Mahrukh Huseni

5

0 references

Yagai Yang

6

0 references

Summer Park

7

0 references

Vincent Javinal

8

0 references

Henry Chiu

9

0 references

Bryan Irving

10

0 references

Dan L Eaton

11

0 references

Jane L Grogan

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection

12

0 references

language of work or name

English

0 references

publication date

8 December 2014

0 references

published in

Cancer Cell

0 references

volume

26

0 references

issue

6

0 references

page(s)

923-37

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Vstm3 is a member of the CD28 family and an important modulator of T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Dendritic-cell-based therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Turning tumors into vaccines: co-opting the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Oncology meets immunology: the cancer-immunity cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Tolerance and exhaustion: defining mechanisms of T cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Cancer immunotherapy comes of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Comprehensive molecular characterization of human colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Comprehensive genomic characterization of squamous cell lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Comprehensive molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Integrated genomic characterization of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Comprehensive molecular characterization of clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

1 reference

7 January 2021

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Molecular mechanisms of T cell co-stimulation and co-inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Nivolumab plus ipilimumab in advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Labeling of fusion proteins with synthetic fluorophores in live cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

The TIGIT/CD226 axis regulates human T cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021

Cutting edge: DNAX accessory molecule 1-deficient CD8+ T cells display immunological synapse defects that impair antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCELL.2014.10.018

7 January 2021